Therapy of Crohn's disease in childhood

Paediatric Drugs

Volumn 2, Issue 3, 2000, Pages 193-203

  Beattie, R Mark ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALICAFORSEN; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; INTERCELLULAR ADHESION MOLECULE 1; METHOTREXATE; METRONIDAZOLE; PLACEBO; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR;

ANTIBIOTIC THERAPY; CORTICOSTEROID THERAPY; CROHN DISEASE; ENDOSCOPY; ENTERIC FEEDING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAINTENANCE THERAPY; NUTRITIONAL SUPPORT; PRIORITY JOURNAL; RELAPSE; REVIEW; TREATMENT PLANNING;

EID: 0034039493     PISSN: 11745878     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128072-200002030-00004     Document Type: Review

References (87)

1. 1. Griffiths AM. Crohn's disease. Recent Adv Paediatr 1992; 10: 145-60
2. 2. Cosgrove M, Al-Ataia RF, Jenkins HR. The epidemiology of inflammatory bowel disease. Arch Dis Child 1996; 74 (5): 460-1
3. 3. Kirschner BS. Inflammatory bowel disease. Ballieres Clin Paediatr 1994; 2 (4): 747-65
4. 4. Murch SH, Walker-Smith JA. Medical management of chronic inflammatory bowel disease. Ballieres Clin Gastroenterol 1994; 8 (1): 133-48
5. 5. Walker-Smith JA. Management of growth failure in Crohn's disease. Arch Dis Child 1996; 55 (10): 351-4
6. 6. Walker-Smith JA. Therapy of Crohn's disease in childhood. Ballieres Clin Gastroenterol 1997; 11 (3): 593-610
7. 7. Chong SKF, Bartram C, Campbell CA, et al. Chronic inflammatory bowel disease in childhood. BMJ 1982; 284: 101-4
8. 8. Chong SKF, Blackshaw AJ, Boyle S, et al. Histological diagnosis of inflammatory bowel disease in childhood. Gut 1985; 26 (1): 55-9
9. 9. Williams CB, Laage NJ, Campbell CA, et al. Total colonoscopy in children. Arch Dis Child 1982; 57: 49-53
10. 10. Jobling JC, Lindley KJ, Yousef Y, et al. Investigating inflammatory bowel disease: white cell scanning, radiology and colonoscopy. Arch Dis Child 1996: 74 (1): 22-6
11. 11. Shah DB, Cosgrove M, Rees JI, et al.The technetium white cell scan as an initial imaging investigation for evaluating suspected childhood inflammatory bowel disease. J Paediatr Gastroenterol Nutr 1997; 25 (2): 524-8
12. 12. Beattie RM, Walker-Smith JA, Murch SH. Indications for investigations of chronic gastrointestinal symptoms. Arch Dis Child 1995; 73: 354-5
13. 13. Brain CE, Savage MO. Growth and puberty in chronic inflammatory bowel disease. Baillieres Clin Gastroenterol 1994; 8 (1): 83-100
14. 14. Siedman E. Nutritional therapy for Crohn's disease: lessons from the Ste.-Justine Hospital experience. Inflamm Bowel Dis 1997; 3: 49-53
15. 15. Thomas AG, Taylor F, Miller V. Dietary intake and nutritional treatment in Crohn's disease. J Paediatr Gastroenterol Nutr 1993; 17 (1): 75-81
16. 16. Griffiths AM, Nguyen P, Smith C, et al. Growth and clinical course of children with Crohn's disease. Gut 1993; 34: 939-43
17. 17. Hildebrand H, Karlberg J, Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Paediatr Gastroenterol Nutr 1994; 18: 165-73
18. 18. Lipson AB, Savage MO, Davies PSW, et al. Acceleration of linear growth following intestinal resection for Crohn's disease. Eur J Paediatr 1990; 149: 687-90
19. 19. Davies G, Evans CM, Shand WS, et al. Surgery for Crohn's disease: influence of site of disease and operative procedure on outcome. Br J Surg 1990; 77: 81-94
20. 20. Murch SH, Lamkin VA, Savage MO, et al. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut 1991; 32: 913-7
21. 21. Thomas AG, Holly JM, Taylor F, et al. Insulin-like growth factor-1, insulin-like growth factor binding protein-1, and insulin in childhood Crohn's disease. Gut 1993; 34: 944-7
22. 22. Beattie RM, Camacho-Hubner C, Wacharasindhu S, et al. Responsiveness of IGF-1 and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease. Clin Endocrinol 1998; 49: 483-9
23. 23. Friedmann M, Strang LB. Effect of long term corticosteroids and corticotrophin on the growth of children. Lancet 1966; 2: 568-72
24. 24. Bruce TE. Emotional sequelae in chronic inflammatory bowel disease in children and adolescents. Clin Gastroenterol 1986; 15 (1): 89-104
25. 25. Axelsson C, Jarnum S. Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease. Scand J Gastroenterol 1977; 12: 89-95
26. 26. O'Morain C, Segal AW, Levi AJ. Elemental diets in the treatment of acute Crohn's disease. BMJ 1980; 281: 1173-5
27. 27. Kirschner BS, Klich JR, Kalman SS, et al. Reversal of growth retardation in Crohn's disease with therapy emphasising oral nutritional restitution. Gastroenterology 1981; 80: 10-5
28. 28. O'Morain C, Segal AM, Levi AJ, et al. Elemental diet in acute Crohn's disease. Arch Dis Child 1983; 53: 44-7
29. 29. Griffiths AM, Ohlsson A, Sherman PM, et al. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology 1995; 108: 1056-67
30. 30. Fernandez-Banares F, Cabre E, Esteve-Copmas M, et al. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease: a meta-analysis of the randomised clinical trials. J Parenter Enteral Nutr 1995; 19: 356-64
31. 31. Wright N, Scott BB. Dietary treatment of active Crohn's disease. BMJ 1997; 314: 454-5
32. 32. Sanderson IR, Udeen S, Davies PSW, et al. Remission induced by elemental diet in small bowel Crohn's disease. Arch Dis Child 1987; 61: 123-7
33. 33. Papadopoulou A, Rawashdeh MO, Brown GA, et al. Remission following an elemental diet or prednisolone in Crohn's disease. Acta Paediatr 1995; 84: 79-83
34. 34. Beattie RM, Schiffrin EJ, Donnet-Hughes A, et al. Polymeric nutrition as primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther 1994; 8: 609-15
35. 35. Ruuska T, Savilahti E, Maki M, et al. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. J Paediatr Gastroenterol Nutr 1994; 19: 175-80
36. 36. Belli DC, Seidman E, Bouthillier L, et al. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology 1988; 94: 603-10
37. 37. Polk DB, Hattner JAT, Kerner JA. Improved growth and disease activity after intermitttent administration of a defined formula diet in children with Crohn's disease. J Parenter Enteral Nutr 1992; 16(6): 499-504
38. 38. Siedman E, Jones A, Issenman R, et al. Relapse prevention/growth enhancement in paediatric Crohn's disease: multicentre randomised controlled trial of intermittent enteral nutrition versus alternate day prednisolone. J Paediatr Gastroenterol Nutr 1996; 23: 344
39. 39. Wilschanski M, Sherman P, Pencharz P, et al. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut 1996; 38: 543-8
40. 40. Rigaud D, Cones J, Le Quintrec Y, et al. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental v polymeric diet. Gut 1991; 32: 1492-7
41. 41. Riordan AM, Hunter JO, Dickinson RJ, et al. Treatment of active Crohn's disease by exclusion diet: East Anglian Multicentre controlled trial. Lancet 1993; 342: 1131-4
42. 42. Gorard DA, Hunt JB, Payne-James JJ, et al. Initial response and subsequent course of Crohn's disease treated with elemental diet or prednisolone. Gut 1988; 34: 1198-202
43. 43. Gonzales Huix F, de Leon R, Fernandez-Banares F, et al. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut 1993; 34: 778-82
44. 44. Teahon K, Bjarnason I, Pearson M, et al. Ten years experience with an elemental diet in the management of Crohn's disease. Gut 1990; 31: 1133-7
45. 45. Fernandez-Banares F, Cabre E, Gonzalez-Huix F, et al. Enteral nutrition as primary therapy in Crohn's disease. Gut 1994; 1: S55-9
46. 46. Middleton SJ, Rucker JT, Kirby GA, et al. Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr 1995; 14: 229-36
47. 47. Beattie RM, Bentsen B, MacDonald TT. Childhood Crohn's disease and the efficacy of enteral diets. Nutrition 1998: 14 (4): 345-50
48. 48. Holt A. Protocol for the use of elemental diets in Crohn's disease. Scientific Hospital Supplies International 1997
49. 49. Pearson M, Teahon K, Levi AJ, et al. Food intolerance and Crohn's disease. Gut 1993; 34: 783-7
50. 50. Beattie RM, Walker Smith JA. Treatment of active Crohn's disease hy exclusion diet. J Paediatr Gastroenterol 1994; 19 (4): 135-7
51. 51. Singleton JW, Hanauer SB, Gitnick GL. Mesalamine capsules for the treatment of active Crohn's disease: results of a 16 week trial. Gastroenterology 1993; 104: 1293-301
52. 52. Malchow H, Ewew K, Brandes JW, et al. European co-operative Crohn's study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 249-66
53. 53. Ferry GD. IBD: which 5 ASA drug works where (selected summaries). J Paediatr Gastroenterol Nutr 1993; 16: 474-5
54. 54. Griffiths A, Koletzko S, Sylvester F, et al. Slow release 5 aminosalicylic acid therapy in children with small intestinal Crohn's disease. J Paediatr Gastroenterol Nutr 1993; 17 (2): 186-92
55. 55. Cowan FJ, Warner JT, Dunstan FD, et al. Inflammatory bowel disease and predisposition to osteopenia. Arch Dis Child 1997; 76 (4): 325-9
56. 56. Sachar DB. Budesonide for inflammatory bowel disease: is it a magic bullet. N Engl J Med 1994: 331: 873-4
57. 57. Gross V, Andus T, Ecker KW, et al. Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide study group. Gut 1998; 42 (4): 493-6
58. 58. Modigliani R, Mary J, Simon J, et al. Clinical, biological and endoscopic picture of attacks of Crohn's disease. Gastroenterology 1991; 98: 811-8
59. 59. Landi B, Anh TN, Cortot A, et al. Endoscopic monitoring of Crohn's disease treatment: a prospective, randomised clinical trial. Gastroenterology 1992; 102: 1647-53
60. 60. Gendre JP, Mary JY, Florent C, et al. Oral mesalamine (pentasa) as maintenance treatment in Crohn's disease: a multi-centre placebo-controlled study. Gastroenterology 1993; 104: 435-9
61. 61. Cosgrove M, Jenkins H. Experience of percutaneous endoscopic gastrostomy in children with Crohn's disease. Arch Dis Child 1997; 76: 141-3
62. 62. Israel DM, Hassal E. Prolonged use of gastrostomy for enteral hyperalimentation in children with Crohn's disease. Am J Gastroenterol 1995; 90 (7): 1084-8
63. 63. Sedgewick DM, Barton JR, Hamer-Hodges DW, et al. Population based study of surgery in juvenile onset Crohn's disease. Br J Surg 1991; 78: 171-5
64. 64. Markowitz J, Rosa J, Grancher K, et al. Long term 6-mercaptopurine treatment in adolescents with Crohn's disease. Gastroenterology 1990; 99: 1347-51
65. 65. Verhave M, Winter HS, Grand RJ. Azathioprine in the treatment of children with inflammatory bowel disease. J Paediatr 1990: 117: 809-14
66. 66. Connell WR, Kamm MA, Dickson M, et al. Long term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994; 343: 1249-52
67. 67. Bouhnik Y, Lemann M, Mary JY, et al. Long term follow up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996; 347: 215-9
68. 68. Brynskov J, Freund L, Rasmussen SN, et al. A placebo-controlled, double blind randomised trial of cyclosporin therapy in active Crohn's disease. N Engl J Med 1989; 321: 845-50
69. 69. Sandborn WJ, Tremaine WJ. Cyclosporin treatment of inflammatory bowel disease. Mayo Clin Proc 1992; 67: 1347-51
70. 70. Egan LJ, Sandhorn WJ, Tremaine WJ. Cyclosporin benefits both refractory and fistulising Crohn's disease. Am J Gastroenterol 1998; 93 (3): 442-8
71. 71. Nicholls S, Domizio P, Williams CB, et al. Cyclosporin as the initial treatment for Crohn's disease. Arch Dis Child 1994; 71: 243-7
72. 72. Mahdi G, Israel DM, Hassall E. Cyclosporin and 6-mercaptopurine for active, refractory Crohn's colitis in children. Am J Gastroenterol 1996; 91 (7): 1355-9
73. 73. Ramakrishna J, Langhans N, Calenda K, et al. Combined use of cyclosporin and azathioprine or 6-mercaptopurine in paediatric inflammatory bowel disease. J Paediatr Gastroenterol Nutr 1996; 22 (3): 296-302
74. 74. Leamann M, Chariot-Prieur C, Mesnard B. Methotrexate for the treatment of Crohn's disease. Aliment Pharmacol Ther 1996; 10 (30): 309-14
75. 75. Mack DR, Young R, Kaufman S, et al. Methotrexate in patients with Crohn's disease after 6-mercaptopurine. J Paediatr 1998: 132: 830-5
76. 76. Murch SH, Braegger CP, Walker-Smith JA, et al. Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993: 34: 1705-9
77. 77. Derkx B, Taminau J, Radema S, et al. Tumour necrosis antibody treatment in Crohn's disease. Lancet 1993; 77: 81-94
78. 78. Van Dulleman HM, Van Deventer SJ, Hommes DW, et al.Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995; 109 (1): 129-35
79. 79. Targan SR, Hanauer SB, van Deventer JH, et al. A short term study of chimeric monoclonal antibody Ca2 to tumour necrosis factor alpha for Crohn's disease. N Engl J Med 1997: 337: 1029-35
80. 80. Yacyshyn BR, Bowen-Yacyskyn MB, Jewell L, et al. A placebo controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease. Gastroenterology 1998; 114 (6): 1133-42
81. 81. Tolia V. Peri-anal Crohn's disease in children and adolescents. Am J Gastroenterology 1996; 91 (5): 922-6
82. 82. Bernstein L, Brandt L, Frank M, et al. Healing of peri-anal Crohn's disease with metronidazole. Gastroenterology 1980; 79: 357-65
83. 83. Solomon MJ, McLeod RS, O'Connor BI, et al. Combination ciprofloxacin and metronidazole in severe peri-anal Crohn's disease. Can J Gastroenterol 1993; 7: 571-3
84. 84. Greenbloom SL, Steinhart AH, Greenberg GR. Combination ciprofloxacin and metronidazole for active Crohn's disease. Can J Gastroenterol 1998; 12: 53-6
85. 85. Thomas GA, Swift GL, Green JT, et al. Controlled trial of antituberculous therapy in Crohn's disease: a five year follow-up study. Gut 1998; 42 (5): 497-500
86. 86. Shand WS. Surgical therapy of chronic inflammatory bowel disease in childhood. Ballieres Clin Gastroenterol 1994; 8 (1): 149-80
87. 87. McLain BI, Davidson PM, Stokes KB, et al. Growth after gut resection for Crohn's disease. Arch Dis Child 1990; 65: 760-2